Share on StockTwits

Cardinal Health (NYSE:CAH) EVP Mark R. Blake unloaded 4,782 shares of Cardinal Health stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $72.15, for a total value of $345,021.30. Following the transaction, the executive vice president now directly owns 22,589 shares of the company’s stock, valued at approximately $1,629,796. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Cardinal Health (NYSE:CAH) traded up 1.19% during mid-day trading on Thursday, hitting $73.34. The stock had a trading volume of 883,517 shares. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock has a 50-day moving average of $71.18 and a 200-day moving average of $69.61. The company has a market cap of $24.690 billion and a P/E ratio of 21.45.

Cardinal Health (NYSE:CAH) last released its earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.25 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.3425 per share. This represents a $1.37 dividend on an annualized basis and a yield of 1.89%. The ex-dividend date of this dividend is Monday, September 29th.

A number of research firms have recently commented on CAH. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Cardinal Health has an average rating of “Buy” and an average price target of $77.93.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.